RB has been the topic of several other reports. Barclays restated an equal weight rating and issued a GBX 6,600 ($88.83) price target (down from GBX 7,100 ($95.56)) on shares of Reckitt Benckiser Group in a research report on Monday, November 27th. Royal Bank of Canada set a GBX 5,600 ($75.37) price target on shares of Reckitt Benckiser Group and gave the company a sell rating in a report on Friday, October 20th. Liberum Capital lowered their price objective on shares of Reckitt Benckiser Group from GBX 8,700 ($117.09) to GBX 8,000 ($107.67) and set a buy rating for the company in a research report on Wednesday, October 25th. Kepler Capital Markets lowered their price objective on shares of Reckitt Benckiser Group from GBX 7,800 ($104.98) to GBX 7,300 ($98.25) and set a hold rating for the company in a research report on Monday, October 9th. Finally, Deutsche Bank restated a buy rating and issued a GBX 8,500 ($114.40) price objective on shares of Reckitt Benckiser Group in a research report on Thursday, October 12th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have given a buy rating to the company. The company has an average rating of Hold and an average target price of GBX 7,723.64 ($103.95).
Reckitt Benckiser Group (LON RB) opened at GBX 6,733 ($90.62) on Monday. Reckitt Benckiser Group has a 12 month low of GBX 6,299 ($84.78) and a 12 month high of GBX 8,110.43 ($109.16).
In other Reckitt Benckiser Group news, insider Christopher Sinclair acquired 2,800 shares of the company’s stock in a transaction that occurred on Wednesday, November 1st. The stock was acquired at an average price of GBX 6,597 ($88.79) per share, for a total transaction of £184,716 ($248,608.34). Also, insider Adrian Nevil Hennah acquired 2,285 shares of the company’s stock in a transaction that occurred on Wednesday, November 8th. The stock was acquired at an average price of GBX 6,567 ($88.38) per share, with a total value of £150,055.95 ($201,959.56).
TRADEMARK VIOLATION WARNING: “Reckitt Benckiser Group (RB) Given a GBX 7,070 Price Target at Goldman Sachs Group” was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://ledgergazette.com/2017/12/12/reckitt-benckiser-group-rb-given-a-gbx-7070-price-target-at-goldman-sachs-group.html.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Receive News & Ratings for Reckitt Benckiser Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.